InspireMD (NSPR) director boosts stake with 75,626-share buy, corrects 10b5-1 and ownership details
Filing Impact
Filing Sentiment
Form Type
4/A
Rhea-AI Filing Summary
InspireMD, Inc. director Paul Stuka reported open-market purchases of 75,626 shares of Common Stock. He bought 65,626 shares on May 8, 2026 at a weighted average price between $1.15 and $1.16, and 10,000 shares on May 11, 2026 at a weighted average price between $1.17 and $1.20.
Following these purchases, he directly beneficially owned 632,871 shares and indirectly, through Osiris Investment Partners, L.P., beneficially owned 423,704 shares. The amendment also corrects earlier reports by confirming certain shares were held directly rather than indirectly and states that these corrections did not change his pecuniary interest. It further clarifies that the transactions were not effected under a Rule 10b5-1(c) trading plan and that the Osiris-held shares are included here for informational purposes only.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 75,626 shares ($88,026)
Net Buy
3 txns
Insider
Stuka Paul
Role
null
Bought
75,626 shs ($88K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 10,000 | $1.19 | $12K |
| Purchase | Common Stock | 65,626 | $1.16 | $76K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 632,871 shares (Direct, null);
Common Stock — 423,704 shares (Indirect, See Footnote)
Footnotes (1)
- The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.15 to $1.16. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. The Form 4 filed on August 1, 2025 (and subsequent Form 4s reflecting this information) inadvertently reported that 20,661 shares of common stock purchased on July 30, 2025 were indirectly held by the Reporting Person through Osiris Investment Partners, L.P. ("Osiris"). However, such shares were held directly by the Reporting Person. After adjusting for the foregoing and further technical adjustments, the Reporting Person (i) directly beneficially owned 557,245 shares of Common Stock and (ii) indirectly, through Osiris, beneficially owned 423,704 shares of Common Stock, in each case immediately prior to the transaction reported herein. This Form 4 reflects the Reporting Person's correct beneficial ownership following the transaction reported herein. No change in the Reporting Person's pecuniary interest resulted from these corrections. The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.17 to $1.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. These securities are held by Osiris. The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. This Form 4/A is being filed solely to reflect that the reported transactions were not effected pursuant to a Rule 10b5-1(c) trading plan. The Form 4 filed on May 12, 2026 (the "Original Filing") inadvertently checked the box that the transactions were effected pursuant to a Rule 10b5-1(c) trading plan. The Reporting Person does not currently maintain any Rule 10b5-1 trading plans. The transaction details otherwise reported in the Original Filing remain accurate and unchanged.
Key Figures
Total shares purchased: 75,626 shares
May 8, 2026 purchase price range: $1.15–$1.16 per share
May 11, 2026 purchase price range: $1.17–$1.20 per share
+3 more
6 metrics
Total shares purchased
75,626 shares
Open-market Common Stock purchases reported in Form 4/A
May 8, 2026 purchase price range
$1.15–$1.16 per share
Weighted average price range for 65,626-share buy
May 11, 2026 purchase price range
$1.17–$1.20 per share
Weighted average price range for 10,000-share buy
Direct holdings after transactions
632,871 shares
Direct beneficial ownership following reported purchases
Indirect holdings via Osiris
423,704 shares
Indirect beneficial ownership through Osiris Investment Partners, L.P.
Direct holdings before transaction
557,245 shares
Direct beneficial ownership immediately prior to reported trades
Key Terms
weighted average price, beneficially owned, pecuniary interest, Rule 10b5-1(c) trading plan, +2 more
6 terms
weighted average price financial
"The price reported is a weighted average price. The reported securities were purchased in multiple transactions…"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficially owned financial
"the Reporting Person (i) directly beneficially owned 557,245 shares of Common Stock and (ii) indirectly…"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
pecuniary interest financial
"No change in the Reporting Person's pecuniary interest resulted from these corrections."
Rule 10b5-1(c) trading plan regulatory
"reported transactions were not effected pursuant to a Rule 10b5-1(c) trading plan."
A Rule 10b5-1(c) trading plan is a legally defined, pre-set schedule that lets company insiders automatically buy or sell stock at specified times or under set formulas when they are not in possession of undisclosed, sensitive information. Think of it like an automatic payment plan for trades: because the instructions are written in advance, trades under the plan help protect insiders from allegations of trading on secret information and give investors clearer expectations about when insiders will transact, which can affect liquidity and perceived transparency.
Section 16 regulatory
"shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes."
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
indirectly financial
"indirectly, through Osiris, beneficially owned 423,704 shares of Common Stock…"
FAQ
What insider transactions did InspireMD (NSPR) disclose in this Form 4/A?
InspireMD disclosed that director Paul Stuka purchased 75,626 shares of Common Stock in open-market transactions. He bought 65,626 shares on May 8, 2026 and 10,000 shares on May 11, 2026, at weighted average prices slightly above one dollar per share.
What corrections to prior InspireMD (NSPR) ownership reporting does this Form 4/A make?
The amendment corrects earlier filings that mistakenly showed 20,661 shares as indirectly held through Osiris. It clarifies those shares were actually held directly by Paul Stuka and updates his direct and indirect beneficial ownership without changing his pecuniary interest in the securities.
Were Paul Stuka’s InspireMD (NSPR) trades under a Rule 10b5-1 trading plan?
The Form 4/A states the transactions were not effected under a Rule 10b5-1(c) trading plan. A prior Form 4 had inadvertently checked the box indicating use of such a plan, and this amendment is being filed solely to correct that disclosure detail.